These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 9684437)

  • 1. Centrally acting antihypertensives: not obsolete after all.
    Schachter M
    Int J Clin Pract; 1998; 52(3):192-5. PubMed ID: 9684437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moxonidine: a review of safety and tolerability after seven years of clinical experience.
    Schachter M
    J Hypertens Suppl; 1999 Aug; 17(3):S37-9. PubMed ID: 10489097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The renaissance of centrally acting antihypertensive drugs.
    van Zwieten PA
    J Hypertens Suppl; 1999 Aug; 17(3):S15-21. PubMed ID: 10489094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moxonidine for hypertension.
    Drug Ther Bull; 1997 May; 35(5):33-6. PubMed ID: 9282418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moxonidine: a new antiadrenergic antihypertensive agent.
    Prichard BN; Graham BR; Owens CW
    J Hypertens Suppl; 1999 Aug; 17(3):S41-54. PubMed ID: 10489098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antihypertensive efficacy of moxonidine in primary care: a 'real-life' study.
    Schachter M; Mitchell G; Niziol C; Abhyankar BA
    Int J Clin Pract; 2003; 57(6):479-82. PubMed ID: 12918886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological properties of the central antihypertensive agent, moxonidine.
    Edwards LP; Brown-Bryan TA; McLean L; Ernsberger P
    Cardiovasc Ther; 2012 Aug; 30(4):199-208. PubMed ID: 21884003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Centrally-acting antihypertensive drugs].
    Takishita S; Yamazato M
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():591-5. PubMed ID: 15171442
    [No Abstract]   [Full Text] [Related]  

  • 9. Antihypertensive drugs and the sympathetic nervous system.
    Del Colle S; Morello F; Rabbia F; Milan A; Naso D; Puglisi E; Mulatero P; Veglio F
    J Cardiovasc Pharmacol; 2007 Nov; 50(5):487-96. PubMed ID: 18030057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renewed interest in centrally acting antihypertensive drugs.
    van Zwieten PA
    Cardiovasc J S Afr; 2000 Aug; 11(4):225-229. PubMed ID: 11447483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of centrally acting sympatholytic agents in the management of hypertension.
    Oster JR; Epstein M
    Arch Intern Med; 1991 Aug; 151(8):1638-44. PubMed ID: 1872668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased sympathetic nervous system activity and its therapeutic reduction in arterial hypertension, portal hypertension and heart failure.
    Esler M; Kaye D
    J Auton Nerv Syst; 1998 Oct; 72(2-3):210-9. PubMed ID: 9851571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New ideas for treating hypertension.
    Schachter M
    J Hum Hypertens; 1995 Aug; 9(8):663-7. PubMed ID: 8523385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The centrally acting drugs.
    Carruthers SG
    J Cardiovasc Pharmacol; 1988; 12 Suppl 8():S74-82. PubMed ID: 2469905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Central nervous system as a target for the new antihypertensive agents].
    Nurminen ML
    Duodecim; 1999; 115(20):2267-73. PubMed ID: 11973931
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of antihypertensive therapies on the sympathetic nervous system.
    de Champlain J; Karas M; Toal C; Nadeau R; Larochelle P
    Can J Cardiol; 1999 Mar; 15 Suppl A():8A-14A. PubMed ID: 10205251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Central and peripheral blockade of the sympathetic nervous system.
    Weber MA; Drayer JI
    Am J Med; 1984 Oct; 77(4A):110-8. PubMed ID: 6148889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Centrally acting antihypertensive drugs: re-emergence of sympathetic inhibition in the treatment of hypertension.
    Benedict CR
    Curr Hypertens Rep; 1999 Aug; 1(4):305-12. PubMed ID: 10981082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of three antihypertensive drug groups on lipid metabolism. Effects of alpha receptor blockers, central sympatholytic drugs and vasodilators].
    Jacob BG; Richter WO; Schwandt P
    Fortschr Med; 1993 Mar; 111(8):126-9. PubMed ID: 8099558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aliskiren: new drug. Arterial hypertension: no evidence of clinical efficacy.
    Prescrire Int; 2008 Apr; 17(94):47-50. PubMed ID: 18516803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.